Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.05 USD | -2.64% | -10.99% | -22.56% |
29/04 | North American Morning Briefing : Investors Brace -2- | DJ |
22/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Sales 2021 | 172M 14.3B | Sales 2022 | 317M 26.4B | Capitalization | 380M 31.72B |
---|---|---|---|---|---|
Net income 2021 | -8M -667M | Net income 2022 | 35M 2.92B | EV / Sales 2021 | 3.44 x |
Net cash position 2021 | 67.84M 5.66B | Net Debt 2022 | 10.19M 849M | EV / Sales 2022 | 1.23 x |
P/E ratio 2021 |
-77
x | P/E ratio 2022 |
10.7
x | Employees | 134 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 65.14% |
Latest transcript on Eagle Pharmaceuticals, Inc.
1 day | -2.64% | ||
1 week | -10.99% | ||
Current month | -22.71% | ||
1 month | -22.71% | ||
3 months | -26.50% | ||
6 months | -70.09% | ||
Current year | -22.56% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 01/13/01 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01/07/01 |
Ryan Debski
CMP | Compliance Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01/07/01 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 28/19/28 |
Richard Edlin
BRD | Director/Board Member | 63 | 17/17/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.54% | 29 M€ | -3.52% | ||
0.25% | 27 M€ | -4.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 4.05 | -2.64% | 188,539 |
26/24/26 | 4.16 | -1.89% | 79,708 |
25/24/25 | 4.24 | -6.81% | 130,193 |
24/24/24 | 4.55 | -4.61% | 95,218 |
23/24/23 | 4.77 | +4.84% | 88,216 |
Delayed Quote Nasdaq, April 30, 2024 at 01:30 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-22.56% | 52.6M | |
+3.30% | 69.85B | |
+11.77% | 8.98B | |
-14.44% | 4.89B | |
+41.60% | 4.44B | |
+5.96% | 3.95B | |
+21.60% | 2.49B | |
-19.32% | 2.4B | |
-27.04% | 2.28B | |
+7.97% | 1.96B |
- Stock Market
- Equities
- EGRX Stock